BioCardia, Inc.
BioCardia develops autologous and allogeneic cell therapies for cardiovascular and pulmonary disease.
8-KNov 12Latest SEC filing
Nov 12Latest story
November 2026
October 2026
September 2026
August 2026
BioCardia develops autologous and allogeneic cell therapies for cardiovascular and pulmonary disease.
November 2026
October 2026
September 2026
August 2026